September 17, 2024 by Noah Fromson, University of Michigan Jacob Dwyer, Justine Ross. Credit: Michigan MedicineDoctors and pharmacists treating people with blood thinners can reduce the rate of inappropriate dosing—as well as blood clots and strokes that can result from it—using an electronic patient management system, a study suggests. The online dashboard, developed by the...
July 31, 2024 by University of Michigan Credit: Pixabay/CC0 Public DomainMillions of Americans take anticoagulants, commonly known as blood thinners. These medications work to prevent blood clots that cause heart attack and stroke. More than two-thirds of those people take a type of blood thinner called a direct oral anticoagulant. DOACs, such as rivaroxaban (brand...
Written by Austin Ulrich, PharmD, BCACP | Reviewed by Christina Aungst, PharmDPublished on June 3, 2024 Key takeaways: Blood thinner medications help prevent and treat blood clots. But they can also increase your risk of bleeding. You shouldn’t combine blood thinners with nonsteroidal anti-inflammatory drugs (NSAIDs). The combination raises your bleeding risk. Many over-the-counter (OTC)...
Researchers examined three of the most commonly prescribed blood thinners for patients with blood clots or atrial fibrillation Reports and Proceedings MICHIGAN MEDICINE – UNIVERSITY OF MICHIGAN When diagnosed with a blood clot or atrial fibrillation, patients are often prescribed anticoagulants, or blood thinners, to prevent a future clot. In a study of the three...
by Columbia University Irving Medical Center Credit: Cell Metabolism (2023). DOI: 10.1016/j.cmet.2023.06.014 Warfarin, a widely used blood thinner, appears to have potent anti-cancer properties, according to a study by Columbia University researchers. The study, conducted in human cells and in mice, found that warfarin stops tumors from interfering with a self-destruct mechanism that cells initiate when they detect...
by Mariah R. Lucas, Pennsylvania State University Co-authors Atip Lawanprasert, doctoral student in biomedical engineering (left), Sopida Pimcharoen, undergraduate student in biomedical engineering (center) and Scott Medina (right), Penn State associate professor of biomedical engineering, analyze results related to their study of combining the anticoagulant heparin with peptide to slow down the medication’s delivery at...
by University College London Credit: Unsplash/CC0 Public Domain A large-scale comparison of direct oral anticoagulants (blood thinners), commonly prescribed for irregular heartbeats, has identified the drug associated with the lowest risk of bleeding, in a new study led by UCL researchers. In the paper published in Annals of Internal Medicine, the researchers report that one of...
by Ana Gajic, St. Michael’s Hospital Graphical abstract. Credit: DOI: 10.1136/bmj.n2400 A high dose of an inexpensive and globally available blood-thinning medication reduces the risk of death in hospitalized patients who are moderately ill with COVID-19, suggests a new study led by St. Michael’s Hospital. Published today in the BMJ, the international RAPID Trial compared the effects...
